Aspen Pharmacare wins Canada approval for generic Ozempic injection
- Posted on July 20, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Aspen Pharmacare wins Canada approval for generic Ozempic injection
JOHANNESBURG, July 20 (Reuters) - South Africa's Aspen Pharmacare said on Monday that its Canadian subsidiary had received regulatory approval from Health Canada for Aspen-Semaglutide, a generic semaglutide injectable used to treat adults with type 2 diabetes. Semaglutide is the active ingredient found in Novo Nordisk's blockbuster Ozempic diabetes treatment and Wegovy weight-loss medicine. (
